Cognitive Impairment, Dementia and Depression in Older Adults

Topic: Risk, prevention and care in population studies

This narrative review integrates longitudinal cohort studies, neuroimaging and biomarker research, and major clinical trials to examine how depression and cognitive decline interact across the dementia continuum. Depression and cognitive impairment frequently co-occur in late life and exhibit substantial clinical and biological overlap. Meta-analytic and large population-based cohort studies consistently show that late-life depression increases the risk of mild cognitive impairment and dementia, with stronger associations observed for vascular dementia than for Alzheimer's disease. Neurobiological studies implicate cerebrovascular pathology, neuroinflammation, hypothalamic-pituitary-adrenal axis dysregulation, and fronto-subcortical circuit dysfunction as key mechanisms linking depressive symptoms to later cognitive decline. In a subset of older adults, new-onset depression-particularly when accompanied by executive dysfunction, subjective cognitive decline, or high white-matter hyperintensity burden-are associated with an increased likelihood of near-term cognitive decline and dementia, although evidence for a definitive prodromal state remains limited. Depression is also highly prevalent as part of the behavioral and psychological symptoms of dementia, occurring in 30-50% of individuals with Alzheimer's disease and even higher proportions in dementia with Lewy bodies or frontotemporal dementia. Comorbid depression in dementia accelerates cognitive and functional decline, increases neuropsychiatric burden, and worsens quality of life for patients and caregivers. Therapeutically, antidepressant treatment may confer modest benefits on mood and selected cognitive domains (e.g., processing speed and executive function) in non-demented older adults, whereas in established dementia, antidepressant efficacy is limited. In contrast, cholinesterase inhibitors, memantine, and multimodal non-pharmacological interventions yield small but measurable improvements in depressive or apathy-related symptoms. Emerging disease-modifying therapies for Alzheimer's disease have demonstrated cognitive benefits, but current trial data provide insufficient evidence regarding effects on depressive symptoms, highlighting an important gap for future research. These findings underscore the need for stage-specific, integrative strategies to address the intertwined trajectories of mood and cognition in aging.

Key findings

• In a subset of older adults, new-onset depression-particularly when accompanied by executive dysfunction, subjective cognitive decline, or high white-matter hyperintensity burden-are associated with an increased likelihood of near-term cognitive decline and dementia, although evidence for a definitive prodromal state remains limited.
• Emerging disease-modifying therapies for Alzheimer's disease have demonstrated cognitive benefits, but current trial data provide insufficient evidence regarding effects on depressive symptoms, highlighting an important gap for future research.
• These findings underscore the need for stage-specific, integrative strategies to address the intertwined trajectories of mood and cognition in aging.

Why it matters

This review found that late-life depression increases the risk of mild cognitive impairment and dementia, with stronger associations for vascular dementia than Alzheimer's disease. It also notes that current trial data provide insufficient evidence about whether emerging Alzheimer's therapies affect depressive symptoms.

Study details

• Study designcohort study
• Evidence strengthModerate

Read the original

• DOI: 10.3390/jcm15031198
• PubMed: 41682879
• Original source →
• Free full text: Journal of Clinical Medicine →

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

@article{jang2026-41682879,
  author  = {Jang, Yoo Jin and Chang, June Ho and Moon, Daa Un and Jeon, Hong Jin},
  title   = {{Cognitive Impairment, Dementia and Depression in Older Adults}},
  journal = {Journal of Clinical Medicine},
  year    = {2026},
  doi     = {10.3390/jcm15031198},
  pmid    = {41682879},
  url     = {https://doi.org/10.3390/jcm15031198}
}

Related studies in Brain tissue and pathology

• Childhood Loneliness and Cognitive Decline and Dementia Risk in Middle-Aged and Older Adults JAMA Network Open · 2025-09-12 · usefulness score 62/100
• Blood-brain barrier breakdown, neuroinflammation, and cognitive decline in older adults Alzheimer's & dementia : the journal of the Alzheimer's Association · 2018-08-14 · usefulness score 58/100
• Higher brain BDNF gene expression is associated with slower cognitive decline in older adults Neurology · 2016-01-27 · usefulness score 53/100
• Perspectives on depression, mild cognitive impairment, and cognitive decline Archives of general psychiatry · 2006-02-01 · usefulness score 50/100
• Neuropathology of older persons without cognitive impairment from two community-based studies Neurology · 2006-06-26 · usefulness score 64/100
• Association between late-life social activity and motor decline in older adults Archives of internal medicine · 2009-06-01 · usefulness score 58/100

Also tagged “prevalence”

1,224 studies in the library carry the topic tag “prevalence”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,224 tagged studies.

• Twenty-year changes in dementia occurrence suggest decreasing incidence in central Stockholm, Sweden Neurology · 2013-04-17 · usefulness score 75/100 · Brain tissue and pathology
• Inequities in dementia diagnosis and care: insights from a universal health care system Alzheimer s & Dementia · 2025-12-01 · usefulness score 41/100 · Risk factors
• “But My Speech Is Fine...”: Expanding the Speech-Language Pathologist’s Role in Nursing Home Dementia Care Innovation in Aging · 2025-12-01 · usefulness score 26/100 · Risk factors

Similar studies

• Cognitive decline in patients with dementia as a function of depression 2011 · Cognitive tests and assessment
• Healthy Lifestyle and Cognition in Older Adults With Common Neuropathologies of Dementia 2024 · Prevention trials
• The neuropathology of older persons with and without dementia from community versus clinic cohorts 2009 · How common it is
• Dementia and cognitive impairment: epidemiology, diagnosis, and treatment 2014 · Getting a diagnosis
• Late-life depression, mild cognitive impairment, and dementia: possible continuum? 2010 · How common it is
• Change in Depression, Confidence, and Physical Function Among Older Adults With Mild Cognitive Impairment 2019 · Treatments

More on Brain tissue and pathology

• A review that covers this ground Cerebral Small Vessel Disease, Hypertension, and Vascular Contributions to Cognitive Impairment and Dementia Hypertension (Dallas, Tex. : 1979) · 2023-11-29 · usefulness score 59/100
• Newest in this subject Inflammatory biomarker candidates in dementia with Lewy bodies: diagnostic classification, clinical associations, and survival Research Square · 2026-11-01 · Preprint — not yet peer-reviewed · usefulness score 16/100
• Newest in this subject TMEM106B C-Terminal fragment aggregation exacerbates α-synuclein and TDP-43 proteinopathy phenotypes bioRxiv · 2026-10-30 · Preprint — not yet peer-reviewed · usefulness score 16/100

See all studies in Brain tissue and pathology →